WayPoint Biomedical Holdings Inc
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests fo… Read more
WayPoint Biomedical Holdings Inc (WYPH) - Total Assets
Latest total assets as of June 2006: $499.87K USD
Based on the latest financial reports, WayPoint Biomedical Holdings Inc (WYPH) holds total assets worth $499.87K USD as of June 2006.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
WayPoint Biomedical Holdings Inc - Total Assets Trend (2004–2005)
This chart illustrates how WayPoint Biomedical Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
WayPoint Biomedical Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2005)
WayPoint Biomedical Holdings Inc's total assets of $499.87K consist of 60.8% current assets and 39.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.6% |
| Accounts Receivable | $6.19K | 9.3% |
| Inventory | $27.84K | 41.9% |
| Property, Plant & Equipment | $23.57K | 35.5% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2004–2005)
This chart illustrates how WayPoint Biomedical Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: WayPoint Biomedical Holdings Inc's current assets represent 60.8% of total assets in 2005, an increase from 0.8% in 2004.
- Cash Position: Cash and equivalents constituted 9.6% of total assets in 2005, up from 0.8% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2004.
- Asset Diversification: The largest asset category is inventory at 41.9% of total assets.
WayPoint Biomedical Holdings Inc Competitors by Total Assets
Key competitors of WayPoint Biomedical Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
WayPoint Biomedical Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - WayPoint Biomedical Holdings Inc generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - WayPoint Biomedical Holdings Inc is currently not profitable relative to its asset base.
WayPoint Biomedical Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.20 | 0.20 |
| Quick Ratio | 0.01 | 0.15 | 0.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-789.20K | $ -95.76K | $ -95.76K |
WayPoint Biomedical Holdings Inc - Advanced Valuation Insights
This section examines the relationship between WayPoint Biomedical Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 354.3% |
| Total Assets | $66.44K |
| Market Capitalization | $0.98 USD |
Valuation Analysis
Below Book Valuation: The market values WayPoint Biomedical Holdings Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: WayPoint Biomedical Holdings Inc's assets grew by 354.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for WayPoint Biomedical Holdings Inc (2004–2005)
The table below shows the annual total assets of WayPoint Biomedical Holdings Inc from 2004 to 2005.
| Year | Total Assets | Change |
|---|---|---|
| 2005-12-31 | $66.44K | +354.26% |
| 2004-12-31 | $14.63K | -- |